GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allied Biotech Corp (ROCO:1780) » Definitions » Total Assets

Allied Biotech (ROCO:1780) Total Assets : NT$2,187.3 Mil (As of Jun. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Allied Biotech Total Assets?

Allied Biotech's Total Assets for the quarter that ended in Jun. 2024 was NT$2,187.3 Mil.

During the past 12 months, Allied Biotech's average Total Assets Growth Rate was -5.40% per year. During the past 3 years, the average Total Assets Growth Rate was 1.50% per year. During the past 5 years, the average Total Assets Growth Rate was 2.90% per year. During the past 10 years, the average Total Assets Growth Rate was 2.00% per year.

During the past 13 years, Allied Biotech's highest 3-Year average Total Assets Growth Rate was 6.40%. The lowest was -0.90%. And the median was 2.10%.

Total Assets is connected with ROA %. Allied Biotech's annualized ROA % for the quarter that ended in Jun. 2024 was 6.42%. Total Assets is also linked to Revenue through Asset Turnover. Allied Biotech's Asset Turnover for the quarter that ended in Jun. 2024 was 0.20.


Allied Biotech Total Assets Historical Data

The historical data trend for Allied Biotech's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allied Biotech Total Assets Chart

Allied Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,947.23 2,260.55 2,441.39 2,183.02 2,078.90

Allied Biotech Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,316.51 2,183.02 2,215.52 2,078.90 2,187.28

Allied Biotech Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Allied Biotech's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=1168.788+910.116
=2,078.9

Allied Biotech's Total Assets for the quarter that ended in Jun. 2024 is calculated as

Total Assets=Total Equity (Q: Jun. 2024 )+Total Liabilities (Q: Jun. 2024 )
=1157.04+1030.242
=2,187.3

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allied Biotech  (ROCO:1780) Total Assets Explanation

Total Assets is connected with ROA %.

Allied Biotech's annualized ROA % for the quarter that ended in Jun. 2024 is

ROA %=Net Income (Q: Jun. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Jun. 2024 ))/ count )
=136.978/( (2078.904+2187.282)/ 2 )
=136.978/2133.093
=6.42 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Allied Biotech's Asset Turnover for the quarter that ended in Jun. 2024 is

Asset Turnover
=Revenue (Q: Jun. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Jun. 2024 ))/ count )
=427.874/( (2078.904+2187.282)/ 2 )
=427.874/2133.093
=0.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Allied Biotech Total Assets Related Terms

Thank you for viewing the detailed overview of Allied Biotech's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Allied Biotech Business Description

Traded in Other Exchanges
N/A
Address
No. 76 Tun Hua S. Road, Sec. 2, 12th Floor, Taipei, TWN
Allied Biotech Corp is a Taiwan based manufacturer of carotenoids. It manufactures carotenoid formulations for the food, supplement and feed industries. The company markets its products under the name Altratene.

Allied Biotech Headlines

No Headlines